Provided by Tiger Trade Technology Pte. Ltd.

Castle Biosciences, Inc.

32.72
+0.39001.21%
Volume:41.53K
Turnover:1.35M
Market Cap:999.58M
PE:-50.02
High:32.72
Open:32.30
Low:32.16
Close:32.33
52wk High:44.28
52wk Low:17.72
Shares:30.55M
Float Shares:28.22M
Volume Ratio:0.40
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6542
EPS(LYR):-0.8334
ROE:-4.20%
ROA:-1.36%
PB:2.13
PE(LYR):-39.26

Loading ...

Nov 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Major Issues Report

Form 8-K - Current report
May 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 01, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2023

Major Issues Report

8-K - Current report